We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Pharmaceutical drug development and commercial manufacturing is complex and risky. Packaging and drug delivery add challenges. With West by your side, you can find solutions to industry challenges such as:
Cell and gene therapies (CGT) are at the forefront of medical innovation, offering potential cures for previously untreatable diseases. These therapies involve manipulating cellular and genetic material to treat or prevent illnesses. These therapies rely on the handling of fragile, high-value biological materials that must remain free from bioburden and other contamination, potent, and safe at every step—from manufacturing through clinical administration.
In an industry defined by innovation, one essential element quietly shapes the success of every injectable therapy: parenteral packaging. Parenteral packaging may sound technical, but its purpose is straightforward - it is the primary container system that holds, protects, and delivers sterile drug products to patients.
“Parenteral” refers to drug products administered by injection, bypassing the gastrointestinal tract. Depending on therapeutic requirements, these injections are delivered through several main routes, each chosen to optimize onset, duration, and patient experience (see illustration and table below).
Pharmaceutical manufacturing is standing at the edge of a technological revolution. For decades, the industry relied on cam-driven systems, and more recently servo-driven mechanisms, to replicate basic human movements. Today, robotics and artificial intelligence (AI) are rewriting the rules of fill-finish operations, ushering in an era of precision, sterility, and adaptability.
Cell and gene therapies (CGT) are at the forefront of medical innovation, offering potential cures for previously untreatable diseases. These therapies involve manipulating cellular and genetic material to treat or prevent illnesses. These therapies rely on the handling of fragile, high-value biological materials that must remain free from bioburden and other contamination, potent, and safe at every step—from manufacturing through clinical administration.
In an industry defined by innovation, one essential element quietly shapes the success of every injectable therapy: parenteral packaging. Parenteral packaging may sound technical, but its purpose is straightforward - it is the primary container system that holds, protects, and delivers sterile drug products to patients.
“Parenteral” refers to drug products administered by injection, bypassing the gastrointestinal tract. Depending on therapeutic requirements, these injections are delivered through several main routes, each chosen to optimize onset, duration, and patient experience (see illustration and table below).
Pharmaceutical manufacturing is standing at the edge of a technological revolution. For decades, the industry relied on cam-driven systems, and more recently servo-driven mechanisms, to replicate basic human movements. Today, robotics and artificial intelligence (AI) are rewriting the rules of fill-finish operations, ushering in an era of precision, sterility, and adaptability.
English
Chinese
